Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
Am J Kidney Dis. 2018 Dec;72(6):790-797. doi: 10.1053/j.ajkd.2018.06.012. Epub 2018 Aug 23.
RATIONALE & OBJECTIVES: Kidney stones have been associated with increased risk for end-stage renal disease (ESRD). However, it is unclear whether there is also an increased risk for mortality and if these risks are uniform across clinically distinct categories of stone formers.
Historical matched-cohort study.
SETTING & PARTICIPANTS: Stone formers in Olmsted County, MN, between 1984 and 2012 identified using International Classification of Diseases, Ninth Revision codes. Age- and sex-matched individuals who had no codes for stones were the comparison group.
Stone formers were placed into 5 mutually exclusive categories after review of medical charts: incident symptomatic kidney, recurrent symptomatic kidney, asymptomatic kidney, bladder only, and miscoded (no stone).
ESRD, mortality, cardiovascular mortality, and cancer mortality.
Cox proportional hazards models with adjustment for baseline comorbid conditions.
Overall, 65 of 6,984 (0.93%) stone formers and 102 of 28,044 (0.36%) non-stone formers developed ESRD over a mean follow-up of 12.0 years. After adjusting for baseline hypertension, diabetes mellitus, dyslipidemia, gout, obesity, and chronic kidney disease, risk for ESRD was higher in recurrent symptomatic kidney (HR, 2.34; 95% CI, 1.08-5.07), asymptomatic kidney (HR, 3.94; 95% CI, 1.65-9.43), and miscoded (HR, 6.18; 95% CI, 2.25-16.93) stone formers, but not in incident symptomatic kidney or bladder stone formers. The adjusted risk for all-cause mortality was higher in asymptomatic kidney (HR, 1.40; 95% CI, 1.18-1.67) and bladder (HR, 1.37; 95% CI, 1.12-1.69) stone formers. Chart review of asymptomatic and miscoded stone formers suggested increased risk for adverse outcomes related to diagnoses including urinary tract infection, cancer, and musculoskeletal or gastrointestinal pain.
The higher risk for ESRD in recurrent symptomatic compared with incident symptomatic kidney stone formers suggests that stone events are associated with kidney injury. The clinical indication for imaging in asymptomatic stone formers, the correct diagnosis in miscoded stone formers, and the cause of a bladder outlet obstruction in bladder stone formers may explain the higher risk for ESRD or death in these groups.
肾结石与终末期肾病(ESRD)风险增加相关。然而,尚不清楚是否存在死亡率风险增加的情况,以及这些风险在临床上不同的结石形成者分类中是否一致。
历史匹配队列研究。
在明尼苏达州奥姆斯特德县,1984 年至 2012 年间通过国际疾病分类,第九版代码确定肾结石患者。无结石代码的年龄和性别匹配的个体为对照组。
在回顾病历后,将结石患者分为 5 个互斥类别:偶发性症状性肾结石、复发性症状性肾结石、无症状性肾结石、单纯膀胱结石和错误编码(无结石)。
ESRD、死亡率、心血管死亡率和癌症死亡率。
采用 Cox 比例风险模型,根据基线合并症进行调整。
总体而言,65 例肾结石患者(0.93%)和 102 例非肾结石患者(0.36%)在平均 12.0 年的随访中发展为 ESRD。在调整了基线高血压、糖尿病、血脂异常、痛风、肥胖和慢性肾脏病后,复发性症状性肾结石(HR,2.34;95%CI,1.08-5.07)、无症状性肾结石(HR,3.94;95%CI,1.65-9.43)和错误编码(HR,6.18;95%CI,2.25-16.93)的肾结石患者发生 ESRD 的风险更高,但偶发性症状性肾结石或膀胱肾结石患者的风险没有增加。无症状肾结石(HR,1.40;95%CI,1.18-1.67)和膀胱结石(HR,1.37;95%CI,1.12-1.69)患者的全因死亡率调整风险更高。对无症状和错误编码肾结石患者的病历回顾表明,与尿路感染、癌症和肌肉骨骼或胃肠道疼痛等诊断相关的不良结局风险增加。
与偶发性症状性肾结石相比,复发性症状性肾结石患者发生 ESRD 的风险更高,这表明结石事件与肾脏损伤有关。在无症状结石患者中进行影像学检查的临床指征、错误编码结石患者的正确诊断以及膀胱结石患者的膀胱出口梗阻的原因可能解释了这些患者发生 ESRD 或死亡的风险更高。